Clinical and Functional Evolution in Subjects with Parkinson’s Disease during SARS-CoV-2 Pandemic

Clinical and Functional Evolution in Subjects with Parkinson’s Disease during SARS-CoV-2 Pandemic

The COVID-19 pandemic has been a stress test for the population, especially for people with chronic disorders such as Parkinson’s disease (PD). In addition to public health restrictions that contrast with PD management recommendations, there were deep changes in health care delivery. This retrospect...

Full description

Saved in:
Bibliographic Details
Published in:Applied sciences Vol. 13; no. 2; p. 1126
Main Authors: Capecci, Marianna, Baldini, Nicolò, Campignoli, Francesca, Lombardo, Lorenzo Pasquale, Andrenelli, Elisa, Ceravolo, Maria Gabriella
Format: Journal Article
Language:English
Published: Basel MDPI AG 01-01-2023
Subjects:
Body mass index
Chronic illnesses
Complications
Coronaviruses
COVID-19
Data analysis
disability
Health care
healthcare
Hospitalization
Movement disorders
Neurological complications
Neurological diseases
Pandemics
Parkinson's disease
Patients
Physical therapy
Population
Public health
Regression analysis
Rehabilitation
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Signs and symptoms
Stress
Subgroups
Trends
Italy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The COVID-19 pandemic has been a stress test for the population, especially for people with chronic disorders such as Parkinson’s disease (PD). In addition to public health restrictions that contrast with PD management recommendations, there were deep changes in health care delivery. This retrospective study evaluates the impact of COVID-19 on the clinical and functional evolution of a cohort of 221 PD patients consecutively referred to the Movement Disorders Center between 2018 and 2021. We analyzed the trend in motor and non-motor symptoms and functional status across years based on the Unified Parkinson’s Disease Rating Scale (UPDRS) and Non-Motor Symptom Scale (NMSS). We also compared the number of emerging complications, neurologic visits, and rehabilitation sessions per subject per year. In 2020, all primary endpoint measures worsened compared to 2019, without age, disease duration, or greater neurologic impairment explaining this outcome. Concurrently, the percentage of patients receiving neurologic visits or rehabilitation sessions reduced by 53% and 58%, respectively. The subgroup analysis of 167 subjects revealed that those who received at least one cycle of rehabilitation sessions in 2020 maintained their independence level. These findings lead to emphasizing the importance of regular monitoring and rehabilitation delivery in people with chronic neurological disorders.
ISSN:2076-3417
2076-3417
DOI:10.3390/app13021126